Teserpaturev/G47 Δ: First Approval

This article summarizes the milestones in the develo pment of teserpaturev/G47Δ leading to this first approval for the treatment of malignant glioma.
Source: BioDrugs - Category: Drugs & Pharmacology Source Type: research